Pravastatin – 50 mg

Brand:
Cayman
CAS:
81093-37-0
Storage:
-20
UN-No:
Non-Hazardous - /

Pravastatin is a potent and competitive HMG-CoA reductase inhibitor (Ki = 2.3 nM for the active, open ring form of the molecule) that is a ring-hydroxylated metabolite of mevastatin (Item No. 10010340).{15312} In vivo, pravastatin reduces total plasma cholesterol levels by 29% in dogs when administered at a dose of 20 mg/kg per day for five weeks. Formulations containing pravastatin have been used to reduce LDL cholesterol and triglyceride levels and increase HDL cholesterol in the prevention of cardiovascular disease.  

 

Available on backorder

SKU: 10010342 - 50 mg Category:

Description

A potent HMG-CoA reductase inhibitor (Ki = 2.3 nM for the active, open ring form of the molecule); a ring hydroxylated metabolite of mevastatin; reduces total plasma cholesterol levels by 29% in dogs when administered at 20 mg/kg per day for five weeks


Formal name: (βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid

Synonyms: 

Molecular weight: 424.5

CAS: 81093-37-0

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cardiovascular System|Cardiovascular Diseases||Research Area|Cardiovascular System|Lipids & Lipoproteins|Cholesterol Metabolism||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Cell Biology|Cell Death|Ferroptosis||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias